BSX · News · 20261104N

Product / Pipeline Progress

BOSTON SCIENTIFIC CORP · 2026-11-04 · Importance 34 · Surprise 42

Boston Scientific agreed to co-fund development of VITALYST, a next-generation heart pump intended for cardiogenic shock, with Blackstone Life Sciences. The report describes this as the first jointly financed medical-technology project between the two organizations. It also reports new SIMPLAAFY clinical-trial results suggesting WATCHMAN FLX Pro may support simplified anticoagulant regimens for some patients with atrial fibrillation.

Key facts